Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
As of today, Moderna(MRNA) shares are valued at $40.81. The company's market cap stands at 16.02B, with a P/E ratio of -5.09.
On 2026-02-07, Moderna(MRNA) stock traded between a low of $39.50 and a high of $41.50. Shares are currently priced at $40.81, which is +3.3% above the low and -1.7% below the high.
Moderna(MRNA) shares are trading with a volume of 8.34M, against a daily average of 11.29M.
In the last year, Moderna(MRNA) shares hit a 52-week high of $55.20 and a 52-week low of $22.28.
In the last year, Moderna(MRNA) shares hit a 52-week high of $55.20 and a 52-week low of $22.28.
MRNA News
In late January 2026, a U.S. District Judge ruled that Moderna must face a US$5 billion patent-infringement lawsuit over its COVID-19 vaccine technology, denyin...
Mixed options sentiment in Moderna (MRNA), with shares down 62c near $40.25. Options volume relatively light with 17k contracts traded and calls leading puts fo...
Tom Gardner outlines two selective AI opportunities and a disciplined portfolio framework for the next three to five years. Motley Fool co-founder and CEO Tom...
Analyst ratings
74%
of 27 ratingsMore MRNA News
If you are wondering whether Moderna's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are sayin...
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Moderna yesterday and set a price target of $28.00. Claim 50% Off TipRanks Premium Unlock hedge...
Jefferies analyst Dennis Ding notes that Judge Wolson issued summary judgment on three matters in a patent fight between Arbutus Biopharma (ABUS) and Moderna (M...
In a memorandum posted to the site of the U.S. District Court for the District of Delaware, a judge wrote in part: “In this case, Arbutus Biopharma (ABUS) Corp....
Moderna (MRNA) announced an update on their ongoing clinical study. Moderna’s latest clinical update centers on a long‑term extension of its cytomegalovirus (C...
Moderna (NasdaqGS:MRNA) announced a global collaboration and license agreement with Recordati to develop and commercialize its investigational mRNA therapy, mRN...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.